General Information
Drug ID
DR00264
Drug Name
Verapamil
Synonyms
(+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Arpamyl; Bosoptin (TN); CP-16533-1; Calan; Calan (TN); Calcan; Cordilox; Covera-HS (TN); D-365; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isoptin (TN); Isotopin; Vasolan; Veracim; Verapamil (Na-Ca chanel blocker); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Verapamilo; Verapamilo [INN-Spanish]; Verapamilum; Verapamilum [INN-Latin]; Veraptin; Verelan (TN); Verexamil
Drug Type
Small molecular drug
Indication Angina [ICD11: BA40] Approved [1]
High blood pressure [ICD11: BA00] Approved [1]
Therapeutic Class
Analgesics
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=2520"></iframe>
3D MOL 2D MOL
Formula
C27H38N2O4
Canonical SMILES
CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC
InChI
InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3
InChIKey
SGTNSNPWRIOYBX-UHFFFAOYSA-N
CAS Number
CAS 52-53-9
Pharmaceutical Properties Molecular Weight 454.611 Topological Polar Surface Area 64
Heavy Atom Count 33 Rotatable Bond Count 13
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 6
XLogP
3.8
PubChem CID
2520
PubChem SID
10525256 , 11120305 , 11120793 , 11121281 , 11121578 , 11122058 , 11335574 , 11360813 , 11362647 , 11364755 , 11365209 , 11367317 , 11367771 , 11369879 , 11370565 , 11370566 , 11372920 , 11373372 , 11374511 , 11375479 , 11375933 , 11378044 , 11424501 , 11461785 , 11466169 , 11467289 , 11485556 , 11485917 , 11489556 , 11492721 , 14784349 , 26751824 , 26751825 , 29221683 , 3153219 , 46508158 , 47217025 , 47291346 , 47291347 , 47440510 , 47515567 , 47589211 , 47885631 , 48035377 , 5635244 , 598709 , 7849415 , 7980877 , 8151673 , 9397
ChEBI ID
ChEBI:9948
TTD Drug ID
D0R0FE
DT(s) Transporting This Drug MDR3 Transporter Info Multidrug resistance protein 3 Substrate [2]
MRP1 Transporter Info Multidrug resistance-associated protein 1 Substrate [3]
OCT1 Transporter Info Organic cation transporter 1 Substrate [4]
OCTN1 Transporter Info Organic cation/carnitine transporter 1 Substrate [5]
OCTN2 Transporter Info Organic cation/carnitine transporter 2 Substrate [6]
P-GP Transporter Info P-glycoprotein 1 Substrate [7]
Drug-Transporter Activity Data
Drug-Transporter Activity Data P-GP Transporter Info Km = 4.06 microM High five cells-MDR1 [8]
P-GP Transporter Info Km = 24 microM Madin-Darby canine kidney cells (MDCKII)-MDR1 [9]
P-GP Transporter Info Km = 2 microM Spodoptera frugiperda (Sf9) cells-MDR1 [10]
P-GP Transporter Info Km = 4.1 microM Spodoptera frugiperda (Sf9) cells-MDR1 [11]
References
1 Verapamil was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. J Biol Chem. 2000 Aug 4;275(31):23530-9.
3 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
4 Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett. 2006 Mar 8;234(1):4-33.
5 Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther. 1999 May;289(2):768-73.
6 Genetic variations of the SLC22A5 gene in the Chinese and Indian populations of Singapore. Drug Metab Pharmacokinet. 2010;25(1):112-9.
7 Improved expression and purification of human multidrug resistance protein MDR1 from baculovirus-infected insect cells. Protein Expr Purif. 2009 Jul;66(1):7-14.
8 Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein. Pharm Res. 2001 Dec;18(12):1660-8.
9 Chalcogenopyrylium compounds as modulators of the ATP-binding cassette transporters P-glycoprotein (P-gp/ABCB1) and multidrug resistance protein 1 (MRP1/ABCC1). J Med Chem. 2012 May 24;55(10):4683-99.
10 Synthesis and evaluation of 3D templates based on a taxane skeleton to circumvent P-glycoprotein-associated multidrug resistance of cancer. Bioorg Med Chem Lett. 2005 May 16;15(10):2601-5.
11 Modulation of drug-stimulated ATPase activity of human MDR1/P-glycoprotein by cholesterol. Biochem J. 2007 Jan 15;401(2):597-605.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.